Home/Filings/4/0001192482-21-000405
4//SEC Filing

Tammara Vijay 4

Accession 0001192482-21-000405

CIK 0001372299other

Filed

May 4, 8:00 PM ET

Accepted

May 5, 8:15 PM ET

Size

23.5 KB

Accession

0001192482-21-000405

Insider Transaction Report

Form 4
Period: 2021-05-04
Tammara Vijay
Vice President
Transactions
  • Sale

    Common Stock

    2021-05-04$13.81/sh2,000$27,6200 total
  • Sale

    Common Stock

    2021-05-04$13.50/sh6,500$87,7500 total
  • Exercise/Conversion

    Common Stock

    2021-05-04$2.94/sh+2,000$5,8802,000 total
  • Sale

    Common Stock

    2021-05-04$13.81/sh2,311$31,9150 total
  • Sale

    Common Stock

    2021-05-04$13.81/sh4,900$67,6690 total
  • Exercise/Conversion

    Common Stock

    2021-05-04$0.51/sh+6,500$3,3156,500 total
  • Exercise/Conversion

    Options (Right to Buy)

    2021-05-044,9000 total
    Exercise: $0.46Exp: 2024-09-18Common Stock (4,900 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2021-05-042,0002,191 total
    Exercise: $2.94Exp: 2026-04-26Common Stock (2,000 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2021-05-046,50058,261 total
    Exercise: $0.51Exp: 2030-01-02Common Stock (6,500 underlying)
  • Exercise/Conversion

    Common Stock

    2021-05-04$0.46/sh+4,900$2,2544,900 total
  • Exercise/Conversion

    Common Stock

    2021-05-04$0.56/sh+2,311$1,3062,311 total
  • Exercise/Conversion

    Options (Right to Buy)

    2021-05-042,31142,578 total
    Exercise: $0.56Exp: 2030-08-14Common Stock (2,311 underlying)
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.35 to $13.71. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]All of the options became exerciable immediately upon grant.
  • [F4]The option, initially representing a right to purchase a total of 77,641 shares, vests and becomes exercisable annually in equal installments over three years commencing on January 2, 2021, subject to continued service with the Company on the applicable vesting dates.
  • [F5]The option, initially representing a right to purchase a total of 50,000 shares, vests and becomes exercisable in equal monthly installments over three years commencing on September 14, 2020, subject to continued service with the Company on the applicable vesting dates.

Issuer

Ocugen, Inc.

CIK 0001372299

Entity typeother

Related Parties

1
  • filerCIK 0001791822

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 8:15 PM ET
Size
23.5 KB